Why VigiLanz

The work we do matters, and we work hard to make it happen. Dynamic. Inquisitive. Smart. Committed. At VigiLanz, you’ll notice that our people are curious and our projects move fast. Our solutions are changing lives for the better, and we look forward to innovating and leading for years to come.

Leadership

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.

With more than two decades of pharmacy services, patient safety, and medication management system experience, Dr. Hayley Burgess has spearheaded many successful initiatives to enhance medication safety and risk mitigation. As Chief Clinical Officer, she provides leadership oversight and strategic vision for the VigiLanz clinical teams, leads regulatory affairs activities, and supports clinical innovations and product development. Prior to VigiLanz, Hayley served as AVP, Pharmacy Services for HCA Healthcare. In this role, she developed the pharmacy services and medication management strategy and vision for 185 hospital and 120 ambulatory surgery center programs.

Shannon joined the VigiLanz team in 2020, and brings over 15 years of healthcare IT marketing and management experience with a strong focus in product marketing, market intelligence, strategic planning and sales enablement. Prior to joining VigiLanz, Shannon held leadership positions at market-leading organizations including Optum, 3M and Wolters Kluwer. Shannon graduated with a BBA in Information Systems Analysis and Design from the Wisconsin School of Business at University of Wisconsin-Madison.

Walker has built a career in healthcare focused on helping growth stage companies surpass their revenue goals.  His specialties include digital health, managed services, and medical device. Over his career Walker has built three national sales organizations leading each of these teams to become the national leader in their respective space.  He received his undergraduate degree from Western Kentucky University with a focus on Advertising as well as Sales and Marketing.

Khai brings over 15 years of experience with information technology and security to his role at VigiLanz. He has spent the majority of his career in finance and insurance/medical, where he established three industry-leading security programs from the ground up. He was previously the Chief Information Security Officer at a Fortune-100 financial institution where he was responsible for its Cybersecurity Program, Security Operations, Identity and Access Management, Governance and Compliance, and the Privacy Program. Khai received a bachelor’s degree in Computer Engineering and Cyber Security from University Illinois Chicago and Western Governors.

Nag has over two decades of experience in software development and has been with the VigiLanz technical team since 2011, where he maintained and improved product and development workflows while increasing the effectiveness of both. As VP of Software Development, he leverages his extensive technical knowledge of VigiLanz to streamline and innovate our business. He received his graduate degree from the Illinois Institute of Technology with a focus on software development and databases.

Chris joined VigiLanz in 2014 as a Pharmacy Product Specialist where he focused on the implementation and on-going support of our Pharmacy and Antimicrobial Stewardship services. Since then he has worked in various roles at VigiLanz and in 2018 began managing our Safety and Discrete Services. Prior to VigiLanz, Chris completed a PGY-1 Pharmacy Practice Residency at the VA in New York City. He was an Assistant Professor of Pharmacy Practice at the Arnold & Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, for three years before taking on a managerial role at Lenox Hill Hospital. Chris earned his PharmD degree from the University of Michigan.

Jocasta joined VigiLanz early 2022 and has since launched VigiLanz University and other process improvement efforts for the organization. Her expertise lies in leading organizational issue resolutions and successfully implementing initiatives that solve for industry challenges. Her health care knowledge draws from PBM, Health System, and Health Plan experience at both the facility and corporate level. Jocasta is a champion for Diversity, Equity, and Inclusion and holds a bachelor’s degree in biology from Lipscomb University, a master’s degree in business administration from Capella University, and a doctor of pharmacy degree from University of Tennessee.

Board of
Directors

+
x

David Goldsteen

Chairman

Dr. Goldsteen is the co-founder of VigiLanz, and serves as Chairman and CEO. He is a founder and former Chairman and CEO of Vascular Science, Inc., purchased by St. Jude Medical (NASDAQ:STJ). He is the founder and Managing Partner of Global Capital Investments, LLC, a boutique merchant banking group. He previously served as a board member/financier of SurVivaLink, a medical device manufacturer sold to Cardiac Science (NASDAQ:DFIB), MediaDVX, a digital media provider sold to NetStar LP, InfoPet, a veterinary microchipping company, and Quantech, Ltd, a medical diagnostics company. From 1988–1993 he served as Vice President of Medical Affairs for Emergency Services at Health One, a predecessor of Allina Hospitals and Clinics, a diversified healthcare delivery organization. Dr. Goldsteen is a graduate of the University of Minnesota Medical School, performing his residency in Internal Medicine at Hennepin County Medical Center in Minneapolis, MN. He received board certifications in internal medicine and emergency medicine. He received his M.B.A. in 1994 from the Carlson School of Management at the University of Minnesota.

+
x

David Abelson

Director

David Abelson, MD has had a career in medicine, health system design, and executive leadership. David trained in general internal medicine and after a time in private practice joined a large integrated delivery system, Park Nicollet Health Services. In 2010 David became CEO of Park Nicollet Health Services and led the direction of Park Nicollet to value-based payment resulting in a merger with HealthPartners in 2013. As Senior Vice President of HealthPartners and CEO of Park Nicollet, David led a delivery system with multiple hospitals, clinics and specialties with a combined annual revenue of $2.2 billion. David retired in 2014 and is now President of the Institute for Clinical Systems Improvement.

+
x

Jeff Zalasky

Director

Jeff Zalasky, JD served as General Counsel for VigiLanz until his retirement in 2014 and currently serves as an observer of the board of directors. He is a vice president of Global Capital Investments, LLC, a boutique merchant banking group. Jeff served on the board of Vascular Science, Inc. prior to its acquisition by St. Jude Medical in 1999, and he was a board observer for MediaDVX. Jeff received his law degree from Hamline University School of Law in St. Paul, Minnesota.

+
x

David Klass

Observer

Dr. Klass is the developer of VigiLanz’s prototype technology and served as Chief Medical Officer from the company’s founding in 2001 through his retirement in 2014. He has had a long-term interest in the logic of pharmacy ordering systems and the relation of these systems to laboratory results and the creation of tools that could mine and combine both systems intelligently. Dr. Klass graduated from the University of Manitoba and the University of Chicago. He lives in Spain and Chicago.

+
x

David Orbuch

Director

David Orbuch is a values-based leader that has successfully led businesses on three continents. David achieves results by leveraging the power of strong and diverse teams, relentlessly focusing on operational excellence, and recognizing that a healthy corporate culture is a sustainable competitive advantage. His core leadership strengths include, financial management, strategy development, business planning, and operational execution. David is also a recognized leader in the area of governance, corporate responsibility and health care compliance

Our Partners

As a part of the VigiLanz Partner Ecosystem, we’ll collaborate to build healthier hospitals. To inquire about a partnership, please complete our contact form.

PARTNER WITH US

Careers

If you’d like to learn more about our culture and possible openings in the future, let us know. We’re always on the lookout for new talent and would love to be in touch.

Current Openings:

Contact Us

Ready to see your data in action?

Request a demo